Selected research
Industry Growth & Trends
Global Cancer Imaging Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cancer Imaging Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cancer Imaging Software market include Imaris, Varian, DOSIsoft, Certis Oncology, MIM Software Inc., Arterys, SIEMENS, Brainomix and Oncology Systems Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cancer Imaging Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cancer Imaging Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Imaging Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Imaging Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cancer Imaging Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cancer Imaging Software Market by Company
Imaris
Varian
DOSIsoft
Certis Oncology
MIM Software Inc.
Arterys
SIEMENS
Brainomix
Oncology Systems Limited
Mirada
GE HealthCare
Mint Medical
Cancer Imaging Software Segment by Type
CT
MRI
MRA
Others
Cancer Imaging Software Segment by Application
Clinical Routine
Clinical Trials
Cancer Imaging Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Imaging Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cancer Imaging Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CT
- MRI
- MRA
- Others
Applications
- Clinical Routine
- Clinical Trials
Companies covered
- Imaris
- Varian
- DOSIsoft
- Certis Oncology
- MIM Software Inc.
- Arterys
- SIEMENS
- Brainomix
- Oncology Systems Limited
- Mirada
- GE HealthCare
- Mint Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cancer Imaging Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cancer Imaging Software Market Size by Region (2021-2032)
- 1.4.1 Global Cancer Imaging Software Market Size by Region (2021-2026)
- 1.4.2 Global Cancer Imaging Software Market Size by Region (2027-2032)
- 1.5 Key Regions Cancer Imaging Software Market Size (2021-2032)
- 1.5.1 North America Cancer Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cancer Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cancer Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cancer Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cancer Imaging Software Market Size Growth Rate (2021-2032)
2 Cancer Imaging Software Market by Type
- 2.1 Type Introduction
- 2.1.1 CT
- 2.1.2 MRI
- 2.1.3 MRA
- 2.1.4 Others
- 2.2 Global Cancer Imaging Software Market Size by Type
- 2.2.1 Global Cancer Imaging Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cancer Imaging Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cancer Imaging Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cancer Imaging Software Market Size by Regions
- 2.3.1 North America Cancer Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cancer Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cancer Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cancer Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cancer Imaging Software Market Size Breakdown by Type (2021-2026)
3 Cancer Imaging Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical Routine
- 3.1.2 Clinical Trials
- 3.2 Global Cancer Imaging Software Market Size by Application
- 3.2.1 Global Cancer Imaging Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cancer Imaging Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cancer Imaging Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cancer Imaging Software Market Size by Regions
- 3.3.1 North America Cancer Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cancer Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cancer Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cancer Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cancer Imaging Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cancer Imaging Software Industry Trends
- 4.2 Cancer Imaging Software Industry Drivers
- 4.3 Cancer Imaging Software Industry Opportunities and Challenges
- 4.4 Cancer Imaging Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cancer Imaging Software Revenue (2021-2026)
- 5.2 Global Cancer Imaging Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cancer Imaging Software Key Company Headquarters & Area Served
- 5.4 Global Cancer Imaging Software Company, Product Type & Application
- 5.5 Global Cancer Imaging Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cancer Imaging Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cancer Imaging Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Cancer Imaging Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Imaris
- 6.1.1 Imaris Company Information
- 6.1.2 Imaris Business Overview
- 6.1.3 Imaris Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Imaris Cancer Imaging Software Product Portfolio
- 6.1.5 Imaris Recent Developments
- 6.2 Varian
- 6.2.1 Varian Company Information
- 6.2.2 Varian Business Overview
- 6.2.3 Varian Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Varian Cancer Imaging Software Product Portfolio
- 6.2.5 Varian Recent Developments
- 6.3 DOSIsoft
- 6.3.1 DOSIsoft Company Information
- 6.3.2 DOSIsoft Business Overview
- 6.3.3 DOSIsoft Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 DOSIsoft Cancer Imaging Software Product Portfolio
- 6.3.5 DOSIsoft Recent Developments
- 6.4 Certis Oncology
- 6.4.1 Certis Oncology Company Information
- 6.4.2 Certis Oncology Business Overview
- 6.4.3 Certis Oncology Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Certis Oncology Cancer Imaging Software Product Portfolio
- 6.4.5 Certis Oncology Recent Developments
- 6.5 MIM Software Inc.
- 6.5.1 MIM Software Inc. Company Information
- 6.5.2 MIM Software Inc. Business Overview
- 6.5.3 MIM Software Inc. Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 MIM Software Inc. Cancer Imaging Software Product Portfolio
- 6.5.5 MIM Software Inc. Recent Developments
- 6.6 Arterys
- 6.6.1 Arterys Company Information
- 6.6.2 Arterys Business Overview
- 6.6.3 Arterys Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Arterys Cancer Imaging Software Product Portfolio
- 6.6.5 Arterys Recent Developments
- 6.7 SIEMENS
- 6.7.1 SIEMENS Company Information
- 6.7.2 SIEMENS Business Overview
- 6.7.3 SIEMENS Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 SIEMENS Cancer Imaging Software Product Portfolio
- 6.7.5 SIEMENS Recent Developments
- 6.8 Brainomix
- 6.8.1 Brainomix Company Information
- 6.8.2 Brainomix Business Overview
- 6.8.3 Brainomix Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Brainomix Cancer Imaging Software Product Portfolio
- 6.8.5 Brainomix Recent Developments
- 6.9 Oncology Systems Limited
- 6.9.1 Oncology Systems Limited Company Information
- 6.9.2 Oncology Systems Limited Business Overview
- 6.9.3 Oncology Systems Limited Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Oncology Systems Limited Cancer Imaging Software Product Portfolio
- 6.9.5 Oncology Systems Limited Recent Developments
- 6.10 Mirada
- 6.10.1 Mirada Company Information
- 6.10.2 Mirada Business Overview
- 6.10.3 Mirada Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Mirada Cancer Imaging Software Product Portfolio
- 6.10.5 Mirada Recent Developments
- 6.11 GE HealthCare
- 6.11.1 GE HealthCare Company Information
- 6.11.2 GE HealthCare Business Overview
- 6.11.3 GE HealthCare Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 GE HealthCare Cancer Imaging Software Product Portfolio
- 6.11.5 GE HealthCare Recent Developments
- 6.12 Mint Medical
- 6.12.1 Mint Medical Company Information
- 6.12.2 Mint Medical Business Overview
- 6.12.3 Mint Medical Cancer Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Mint Medical Cancer Imaging Software Product Portfolio
- 6.12.5 Mint Medical Recent Developments
7 North America
- 7.1 North America Cancer Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cancer Imaging Software Market Size by Country (2021-2026)
- 7.3 North America Cancer Imaging Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cancer Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cancer Imaging Software Market Size by Country (2021-2026)
- 8.3 Europe Cancer Imaging Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cancer Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cancer Imaging Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cancer Imaging Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cancer Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cancer Imaging Software Market Size by Country (2021-2026)
- 10.3 South America Cancer Imaging Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cancer Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cancer Imaging Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cancer Imaging Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst